Статья
ЗНАЧЕНИЕ ИСХОДНОГО УРОВНЯ АКТИВНОСТИ АНГИОТЕНЗИН- ПРЕВРАЩАЮЩЕГО ФЕРМЕНТА У БОЛЬНЫХ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ ПРИ НАЗНАЧЕНИИ ИНГИБИТОРОВ АПФ И АГОНИСТОВ ИМИДАЗОЛИНОВЫХ РЕЦЕПТОРОВ
Значение исходного уровня активности ангиотензин-превращающего фермента у больных сметаболическим синдромом при назначении ингибиторов АПФ и агонистов имидазолиновых рецепторов.
1. Mogensen C.E., Hansen K.W. Preventing and postponing renal disease in insulin-dependent diabetes by glycemic and non- glycemic intervention. // Contrib Nephrol 1990; 78: 73-100.
2. Gall M.A., Passing P., Skott P., et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulindependent) diabetic patients. // Diabetologia 1991; 34:655-661.
3. Ritz E., Hasslacher C, Mann J., Guo Ji-Zhen. Hypertension and vascular disease as complications of diabetes. // J.Hypertension 1997; 7:233-240
4. Reaven GM. Role of insulin in human disease. // Diabetes 1988; 37: 1595-1607.
5. Ю.В. Зимин. Артериальная гипертония при сахарном диабете: особенности патогенеза и лечения. // Кардиология 1997;11:81-90.
6. Н. Laragh, B.M. Brenner. J. Hypertension: pathophysiology, diagnosis and treatment. New York: Raven Press 1990; 1703-1715
7. Isfan NW, Plaisted CS, Bistrian BR, Blakburn GL. Insulin resistance versus insulin secretion in hypertension of obesity. // J. Hypertension 1992; 19: 385-392.
8. Ferrannini, Andrea N. Insulin Resistance, Hyperinsulinernia and Blood pressure. // J. Hypertension 1997; 30(5):1144-1149.
9. Caro J.F. Insulin resistance in obese and nonobese man. //J.Clinical Endocrinology Metabolism 1991; 73: 691-695.
10. W.Ferrannmi E, Buzzigoli G, Bonnadonna R, et al. Insulin resistance in essential hypertension. // N.Engl.J.Med. l987; 317: 350-357.
11. Lithell H. Effect of antihypertensive drugs in insulin, glucose and lipid metabolism. // Diabetes Care 1991; 14: 203-209.
12. Weinberger ME. Antihypertensive therapy and lipids. Evidence, mechanisms and implications. // Arch.Intern.Med. 1985;145:1103-1105.
13. Cutler R. Effects of antihypertensive therapy on lipid metabolism.// Am. J. Cardiol 1983; 51:628-631.
14. Kaplan NM. Problems with the use of diuretics in the treatment of hypertension. // Am. J. Nefrol. 1986; 6:1-5.
15. KnochelJ. Diuretoc-induced hypokalemia.//Am.J.Med. 1984;77:18-27.
16. Te-Chao F., Wann-Chu H. Role of angiotensin II in Hyperinsulinemia-induced hypertension in rats. // J. Hypertension 1998; 16(2,Part 1): 1767-1771.
17. Lender D, Arauz-Pacheco C, Breen L, et al: A Double Blind Comparison of the Effects of Amlodipin and Enalapril on Insulin Sensitivity in Hypertensive Patients. // Am. J. Hypertension 1999; 12:298-303.
18. Takezako T, Saku K, Zhang B, et al. Angiotensin I Converting Enzyme Gene Polymorphism and Insulin Resistance in Patients with Angina Pectoris. // American J. Hypertension 1999; 12:291-297.
19. MJA Saad, Univ Estadual Campinas. Effect of captopril, losartan and bradykinin on early steps of insulin action. // Diabetes 1997; 46(12):1950-1957.
20. Henriksen et al. Imidazoline Receptors and Muscle Glucose Transport. // J.Hypertension 1997;30(6):1559-1567.
21. Bousquet P, Dontenwill M, Greney H, et al. Imidazoline receptors: an update. // J. Hypertension 1998;16(Suppl 3):S1-S5.
22. Ernsberger P., Separovic D., Kester M. Imidasoline I-1-receptor as a therapeutic target in hypertension and syndrome X. Imidasoline I-1-Receptor Agonists: New Date On Hypertension and related Pathologies.- XVIII Congress of the ESC.-Abstracts.-Birmingham, August 28,1996.
23. Faulds D. Moxonidine: a review of its pharmacology , and its therapeutics use in essential hypertension. //Drugs 1992; 44: 993-1012.
24. Brian NC Prichard, Barrie R. Graham and Chris WI Owens. Moxonidine: a new antiadrenergic agent. // J. Hypertension 1998;17:344-350
25. Haenni A, Lithell H. Moxonidine improves insulin sensetivity in insulin�resistant hypertensive. //J. Hypertension 1999; 17 (Suppl 3): S29-S35.
26. Litthel H. Consideration in treatment of insulin - resistance and related disorders with a new sympatholytic agent.- Imidasoline 1-1- Receptor Agonists: New Date On Hypertension and related Pathologies.- XVIII Congress of the ESC.
27. Kaan CE, Bruckner R, Frohly P et al. Effects of agmatinne and moxonidine on glucose metabolism: An integrated approach towards pathophysiological mechanism in cardiovascular metabolic disorders. // J.Cardiovascular Risk Factors 1995; (5,Supll.): 19-27.
28. Watanabe K, SeriyaM, Takasci Kameoka et al. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension. // J. Hypertension 1999; 17:1161-1168.
29. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. // Clin.Chem. 1973; 19:476- 479.
30. Roeschlau P, Berndt E, Gruber W. Enzimatische bestimmung des desant cholesterines in serum. // Z. Klin. Chem. Klin. Biochem. 1974; 12: 226-229.
31. Assmann G, Schriewer H, Schmitz G, Hedele E. Quantification of high density lipoprotein cholesterol by precipitation with phosphotungstic acid/ MgCk. // Clin.Chem. 1983; 29: 2025-2029.
32. Stems WE, Heder G, Komissarova NW. Vertahren zur Bastimmung des Angiotensin - Converting Enzymes. // Z.Med.Labor.Diagn. l985;26:232-234.
33. Metelskoya V, Serolyuk A, Mamedov M, Konstantinov V, Perova N,Oganov R. Insulin resistance markers for coronary heart disease high risk subject selection. In: Advances in lipoprotein and Atherosclerosis Research, Diagnostics and Treatment. // Gustav Fischer.1997: 192-195.
34. Cardillo C, Nambi S, Crescence M et al. Insulin Stimulates Both Endothelin and Nitric Oxide Activity in the Human Forearm. // Circulation 1999; 100:820-825.
35. Yang X, Liu Y, Edward G. et al. Endothelial Nitric Oxide Gene Knockout Mice. // J. Hypertension 1999; 34: 24-30.
36. Hayakawa H, Raij L. Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension. // J. Hypertension 1999;17:611-619.
37. Opie LH. Angiotensin Converting Enzyme Inhibitors. / University of Cape Town Press 1999; 236.
38. Mutter DN, Fischli W, Clozel J et al. Local Angiotensin II Generation in the Rat Heart./University of Cape Town Press 1999; 244-256.